Advertisement
Screener

Nuo Therapeutics, Inc. (AURX) Cash and Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect

2.9 / 5 stars · 32/56 Roast Me

Nuo Therapeutics, Inc. Cash and Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect

Nuo Therapeutics, Inc. (AURX) reported Cash and Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect of -$2.29 million for the 6-month period ending 2017-06-30, per its 10-Q filed 2017-08-14.

Discontinued › Cash Flow › Change in Cash

us-gaap:CashAndCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect · last filed 2017-08-14

  • Nuo Therapeutics, Inc. cash and cash equivalents, period increase (decrease), excluding exchange rate effect for the quarter ending 2017-03-31 was -$1.28M.
Period endCash and Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect 2 monthCash and Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect 3 monthCash and Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect 6 monthCash and Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect 8 month
2017-06-30-$2.29M
10-Q · filed 2017-08-14
2017-03-31-$1.28M
10-Q · filed 2017-05-15
2016-12-31-$7.74M
10-K · filed 2017-03-29
2016-06-30-$4.29M
10-Q · filed 2017-08-14